Lugtenburg EJ, Brown P, van der Holt B, et al. Rituximab maintenance for patients with diffuse large B-cell lymphoma in first complete remission: Results from a randomized HOVON-Nordic Lymphoma Group phase III study. ASCO Annual Meeting 2019, abstract 7507.
AI-biomarker voor respons op atezolizumab-bevacizumab bij HCC
jan 2024 | Maag-darm-leveroncologie